
Pfizer/BioNTech says its Covid-19 vaccine is 100% effective and well tolerated in adolescents
CNN
Clinical trial results of Pfizer/BioNTech's Covid-19 vaccine show it is 100% efficacious and well tolerated in youths 12-15.
Pfizer/BioNTech plan to submit the data to the US Food and Drug Administration as soon as possible for expanded emergency use authorization of the two-dose vaccine. In a Phase 3 trial of 2,260 participants ages 12 to 15 in the US, the vaccine elicited strong antibody responses one month after the second dose -- exceeding those demonstrated in people ages 16 to 25 in previous trials, Pfizer reported. The vaccine is currently authorized in the US for emergency use in people 16 and older.
5 things to know for March 16: War with Iran, Oscar winners, Travel chaos, Severe weather, US airmen
CNN’s 5 Things AM brings you the news you need to know every morning.

The retirement of Illinois Sen. Dick Durbin after nearly 30 years in office sparked an expensive three-way Democratic primary that has showcased the party’s divisions over how to confront President Donald Trump’s immigration crackdown and introduced pro-crypto forces as an influence seeking to shape the midterm elections. The contest is also setting up a test of Gov. JB Pritzker’s political clout in the state as he eyes a potential 2028 presidential bid.

Raúl Guillermo Rodríguez Castro, grandson of former Cuban President Raúl Castro, appeared for the first time alongside Cuban President Miguel Díaz-Canel at two public events on Friday, raising questions, according to analysts, about his role in Cuba’s leadership as the island faces calls for regime change from the United States.










